ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 505

Characterization of an in Vitro Model of Human Salivary Gland for Studying Sjögren Syndrome (SS)

M. Jesus Dominguez-Luis1, M.Teresa Arce-Franco1, Estefania Armas-Gonzalez1, Ada Herrera-Garcia1, Teresa Giraldez2, Pablo Miranda2, Diego Alvarez de la Rosa3, Jose Garcia-Verdugo4, Carlos Martinez-Jimeno5 and Federico Diaz-Gonzalez1, 1Rheumatology Service. Hospital Universitario de Canarias., La Laguna, Spain, 2Unidad de Investigación of Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain, 3Department of Physiology. Universidad de La Laguna,, La Laguna, Spain, 4Cellular Morphology Laboratory, Centro de Investigación Príncipe Felipe., Valencia, Spain, 5Maxilofacial Department, Hospital Universitario de Canarias,, La Laguna, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and cytokines

  • Tweet
  • Email
  • Print
Session Information

Title: Sjögren's Syndrome - Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Sjögren’s syndrome (SS) is an autoimmune exocrinopathy of unknown etiology that is characterized by decreased salivary secretion (xerostomy) and lacrimal (xerophthalmy). Histopathological lesions of the glandular tissue in SS are characterized by the presence of mononuclear cell infiltrates and acinar atrophy. Studies on the pattern of inflammatory mediators have shown high amounts of IL-2, IFN-γ, IL-10, IL-1β, IL-6, SDF-1α and TNF-α. However, little is known about the implication of this cytokine profile in de SS pathogenesis. Objectives:1) to establish and characterize a model of human salivary gland in vitro, and 2) analyze if this model the functional effect of proinflammatory mediators present in the glandular microenvironment of SS patients.

Methods:  human epithelial cells from biopsies of non-cancerous parotid gland, were enzymatically dispersed, cultured and expanded in medium MCDB153 supplemented with insulin, hydrocortisone and epidermal growth factor. Proliferation assays were performed using a cell proliferation kit. The expression of amylase, VAMP-2, SMA1 and epithelial sodium channels (ENaC), were studied by immunofluorescence in confocal microscopy. The gene expression of the mineralocorticoid receptor, sodium channels (α, β, γ) and a number of genes characteristic of ducts or acini were analyzed by real-time RT-PCR. For the functional study of sodium channels in the plasma membrane were determined by patch clamp assays. Amylase activity in cell-free supernatant was assayed by a fibril-degradation assay and was used as a surrogate marker of exocrine gland function.

Results:  Cells from human salivary gland had morphology of epithelial cells and were able to proliferate in culture. The pattern of gene expression of these cells was more compatible with an acinar rather than ductal origin. Furthermore, the functionality of epithelial sodium channel in their surface was analyzed by patch clamp experiments. The presence of 10μM isoproterenol and 2 mM Ca++ for 24 hours increased three times the basal activity of amylase in the cell-free supernatant of these cells. Moreover, the presence of TNF-α and SDF-1α  caused a significant dose-response reduction in the amylase activity in the cell-free supernatant.

Conclusion: It is possible to set up a functional model of human salivary gland in vitro that allows the development of studies which could lead to better understanding of the pathogenesis of SS and may help to develop therapeutic interventions for this disease.


Disclosure:

M. J. Dominguez-Luis,
None;

M. T. Arce-Franco,
None;

E. Armas-Gonzalez,
None;

A. Herrera-Garcia,
None;

T. Giraldez,
None;

P. Miranda,
None;

D. Alvarez de la Rosa,
None;

J. Garcia-Verdugo,
None;

C. Martinez-Jimeno,
None;

F. Diaz-Gonzalez,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characterization-of-an-in-vitro-model-of-human-salivary-gland-for-studying-sjogren-syndrome-ss/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology